Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials.

Kurhanewicz, J

Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. [electronic resource] - Urology Apr 2001 - 124-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review

1527-9995

10.1016/s0090-4295(00)00955-9 doi


Citric Acid--metabolism
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Neoplasm Proteins--metabolism
Patient Selection
Prostate--pathology
Prostate-Specific Antigen--metabolism
Prostatic Neoplasms--diagnosis